STRS Ohio’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

STRS Ohio’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,500	Closed	-$21K	–	2017
2016 Q3	$21K	Sell	1,500 -1,700	-53%	-$24.1K	﹤0.01%	1841
2016 Q2	$38K	Hold	3,200	–	–	﹤0.01%	1813
2016 Q1	$59K	Hold	3,200	–	–	﹤0.01%	1748
2015 Q4	$68K	Hold	3,200	–	–	﹤0.01%	1746
2015 Q3	$54K	Hold	3,200	–	–	﹤0.01%	1753
2015 Q2	$120K	Buy	+3,200	New	+$103K	﹤0.01%	1655

Other funds holding CBMG

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

STRS Ohio's CBMG Position: Q4 2016 in Review

STRS Ohio sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q4 2016, closing a stake of 1,500 shares — an estimated $21K sold.

STRS Ohio first reported a position in CBMG in Q2 2015 and held it in 6 quarters. The position peaked at $120K in Q2 2015. 38 funds tracked by Wall St. Rank hold CBMG as of Q4 2016.

STRS Ohio reported no remaining Cellular Biomedicine Group, Inc. position as of Q4 2016 after selling out during the quarter.
STRS Ohio sold 1,500 Cellular Biomedicine Group, Inc. shares in Q4 2016, an estimated $21K.
STRS Ohio first reported a position in Cellular Biomedicine Group, Inc. in Q2 2015 and held it in 6 quarters.
STRS Ohio's Cellular Biomedicine Group, Inc. position peaked at $120K in Q2 2015.
38 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q4 2016.

Based on STRS Ohio's 13F filing for Q4 2016, filed 24 Jan 2017.